Beyond US: New shores, new bets
The US remains a key market for Indian pharma. But changing conditions are…
Interviews
India’s biotech growth story is now a manufacturing story: G Balaji
As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G…
Why industry-academia collaboration will shape India’s next R&D chapter
Suneela Thatte, VP & Head, Merck Healthcare R&D India in an exclusive conversation with Swati Rana, speaks about the…
Beyond cost what will shape India’s pharma competitiveness?
Christoph Funke, Chief Technical Operations Officer, Lupin, explains why India’s pharma industry needs to look beyond its cost…
